Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
Newby, L Kristin, Marber, Michael S, Melloni, Chiara, Sarov-Blat, Lea, Aberle, Laura H, Aylward, Philip E, Cai, Gengqian, de Winter, Robbert J, Hamm, Christian W, Heitner, John F, Kim, Raymond, LermanVolume:
384
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(14)60417-7
Date:
September, 2014
File:
PDF, 493 KB
english, 2014